9:22 AM
Leo Group India
| ||
| Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2012 Financial ... MarketWatch (press release) WEIFANG, China, May 16, 2012 /PRNewswire via COMTEX/ -- Shengtai Pharmaceutical, Inc. (OBB:SGTI) (''Shengtai'' or ''the Company'' or "we" or "us"), a manufacturer and distributor in China of glucose and starch as pharmaceutical raw materials and other ... See all stories on this topic » | ||
| Catalyst Pharmaceutical Partners Announces First Quarter 2012 Financial Results MarketWatch (press release) CORAL GABLES, Fla., May 16, 2012 (GlobeNewswire via COMTEX) -- Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) today announced its financial results for the three month period ended March 31, 2012. The Company reported a net loss of $1089186, ... See all stories on this topic » | ||
| Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of ... MarketWatch (press release) SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire via COMTEX/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced the upcoming presentations of data highlighting Nexavar® (sorafenib) tablets, Kyprolis(TM) (proposed trademark for ... See all stories on this topic » | ||
| Cubist Pharmaceuticals Marks 20th Anniversary by Making Its Largest-Ever ... MarketWatch (press release) LEXINGTON, Mass., May 16, 2012 (BUSINESS WIRE) -- Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that it has awarded nearly $300000 in grants this year to benefit 16 organizations with science, technology, engineering, and mathematics ... See all stories on this topic » | ||
| Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral ... MarketWatch (press release) JERUSALEM, May 16, 2012 (BUSINESS WIRE) -- Marking a major milestone for the company, Oramed Pharmaceuticals Inc. (OBB:ORMP) ( www.oramed.com ), a developer of oral drug delivery systems, announced today that it has received approval for a key patent ... See all stories on this topic » | ||
| FIPB may be allowed to clear foreign buys in pharma companies Times of India NEW DELHI: The Department of Pharmaceuticals has mooted a proposal to allow the country's foreign investment approving body to continue clearing stake purchases by foreign firms in Indian drug companies, as it seeks to end the uncertainty that has ... See all stories on this topic » | ||
| Skystar Bio-Pharmaceutical Reports First Quarter 2012 Results MarketWatch (press release) XI'AN, CHINA, May 16, 2012 (MARKETWIRE via COMTEX) -- Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, ... See all stories on this topic » | ||
| Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for ... MarketWatch (press release) SAN DIEGO, May 16, 2012 /PRNewswire via COMTEX/ -- Elevation Pharmaceuticals, Inc., a pharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today positive results from a Phase 2b ... See all stories on this topic » | ||
| Aoxing Pharmaceutical Company Announces Third Quarter Fiscal 2012 Financial ... MarketWatch (press release) JERSEY CITY, NJ, May 15, 2012 (MARKETWIRE via COMTEX) -- Aoxing Pharmaceutical Company, Inc. (ASE:AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management ... See all stories on this topic » | ||
| Astex Pharmaceuticals to Present at ASCO Annual Meeting MarketWatch (press release) DUBLIN, Calif., May 16, 2012 (GlobeNewswire via COMTEX) -- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the acceptance of three ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment